News UK watchdog says MSD may have blocked Remicade biosimilars MSD may have abused dominant market position, says CMA.
News Sales of Keytruda double ahead of key lung cancer decision FDA to make decision on wider lung cancer use within a week.
News J&J's Remicade faces further biosimilar competition in US FDA approves Samsung Bioepis biosimilar.
News Keytruda in new lymphoma use leads latest CHMP decisions MSD keeps pressure on BMS with EU classical Hodgkin lymphoma indication.
News NICE rejects Opdivo in blood cancer, asks for more data Merck's rival Keytruda gets new US indication.
Sales & Marketing Biotech is back, with Craig Ackerman In Philadelphia this month, pharmaphorum spoke with Craig Ackerman, a partner at the Alexander Group, about launches, AI best practices, and more.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
